The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2431/11/18/prepub We acknowledge the samples provided by the infants enrolled in a clinical trial at the comprehensive care clinic at Kenyatta National Hospital, Nairobi, Kenya.
Of course, such projections must acknowledge the small sample size – even in a season preceded by some semblance of training camp normalcy.
We acknowledge the small sample size, although results were extremely consistent across both patients and all bone structures and they are thus likely generalizable to cranio-maxillofacial bone 3D printing.
Among the study limitations we acknowledge the small sample size that has probably limited power to detect associations with small effect sizes and associations with rare variants.
We acknowledge the small sample size of the clinical study.
We acknowledge the limited sample size of the entire cohort and especially the non-Hispanic groups.
We acknowledge the small sample size and lack of heterogeneity of our cohort.
Second, we acknowledge the small sample size in some categories, which limits statistical power.
It is important however, to acknowledge the small sample sizes used in this study for both FP infected and non infected turtle individuals, as this may not fully represent the actual CFPHV infectivity prevalence.
